Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 19 September 2024
      News
 
  17 September 2024 EFPIA responds to the announcement of the College of Commissioners and publication of their...

EFPIA, Vaccines Europe and our members congratulate all the Commissioner-designates on their proposed roles.  

Read more →
 
 
 
      Recently published
 
  24 July 2024 EFPIA position on EHDS

The EHDS will require the public and private sectors to work together in new and innovative ways. We look forward to...

Read more →
 
 
 
  08 July 2024 Breaking down barriers: Making cross-border access to clinical trials a reality

Collaborative effort by EFGCP and EFPIA develops action plan to address participation barriers in Europe

Read more →
 
 
 
      Have you missed the IHI masterclass on data sharing in collaborative projects?

Watch the recording here.

 
 
 
      Events
 
 
24 SEP 2024
  DIA Medical Information & Communications Conference London, UK

The 2024 DIA Medical Information and Communications Conference is designed for medical information professionals and...

Learn more →
 
 
 
26 SEP 2024
  Bridging the Gap: The New Pan-European Observatory as a Catalyst for EHDS Implementation... Vienna and online

Explore how the H2O Pan-European Observatory can play a pivotal role in aligning digitally captured patient outcomes...

Learn more →
 
 
 
27 SEP 2024
  Why tackling chronic disease is a priority for Europe: Restating the case for investing... Hybrid event - Bad Hofgastein, Austria

As Europe faces demographic, economic, and geopolitical challenges that make it difficult to increase health budgets,...

Learn more →
 
 
      The value of prevention for economic growth and the sustainability of healthcare, social care and welfare systems

Over the last decade, the EU economy has experienced slow growth, and it is not expected to grow substantially in the coming years. Additionally, the ongoing demographic and epidemiological transition is increasing pressure on public finances, particularly healthcare and social expenditure.

The current permacrisis – encompassing geopolitical and climate-related challenges – exacerbates these issues and directly threatens fiscal sustainability through slower economic growth, increased Government deficits, and consequently, higher public debt levels. Addressing these intertwined challenges is essential to ensure the long-term sustainability of healthcare, social care, and welfare systems across the EU.

Read the full report by the European House – Ambrosetti.

 
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe